Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2012; 18(21): 2704-2711
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2704
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2704
Table 2 Cell cycle of HepG-2 treated with gamma-aminobutyric acid at serial concentrations (mean ± SD, n = 3, μmol/L)
| 0 | 1 | 10 | 20 | 40 | 60 | |
| G0/G1 (%) | 40.9 ± 2.92 | 39.6 ± 2.73 | 33.8 ± 2.79 | 31.7 ± 2.56 | 30.2 ± 2.17 | 47.2 ± 2.93 |
| G2/M (%) | 18.1 ± 0.84 | 19.8 ± 0.97 | 20.7 ± 0.85 | 21.3 ± 0.79 | 20.3 ± 1.18 | 18.5 ± 1.23 |
| S (%)a | 31.0 ± 1.89 | 30.6 ± 1.94 | 35.5 ± 2.28 | 37.0 ± 2.17 | 39.5 ± 2.34 | 34.3 ± 2.02 |
- Citation: Li YH, Liu Y, Li YD, Liu YH, Li F, Ju Q, Xie PL, Li GC. GABA stimulates human hepatocellular carcinoma growth through overexpressed GABAA receptor theta subunit. World J Gastroenterol 2012; 18(21): 2704-2711
- URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2704.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2704